| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.73B | 4.56B | 4.32B | 3.62B | 3.54B |
| Gross Profit | 1.58B | 1.47B | 1.30B | 994.65M | 1.07B |
| EBITDA | 698.59M | 541.05M | 374.42M | 291.58M | 291.03M |
| Net Income | 346.25M | 282.76M | 186.74M | 188.69M | 125.95M |
Balance Sheet | |||||
| Total Assets | 5.71B | 5.50B | 5.11B | 4.79B | 4.75B |
| Cash, Cash Equivalents and Short-Term Investments | 760.18M | 675.44M | 545.68M | 434.97M | 658.45M |
| Total Debt | 1.91B | 1.69B | 1.40B | 1.46B | 1.50B |
| Total Liabilities | 3.45B | 3.45B | 3.13B | 2.93B | 2.91B |
| Stockholders Equity | 2.19B | 2.01B | 1.94B | 1.82B | 1.80B |
Cash Flow | |||||
| Free Cash Flow | 434.96M | 344.29M | 258.41M | -116.30M | 195.18M |
| Operating Cash Flow | 505.88M | 425.31M | 325.77M | -40.01M | 250.12M |
| Investing Cash Flow | -125.16M | -387.21M | -68.58M | -6.09M | -59.48M |
| Financing Cash Flow | -326.93M | 117.50M | -153.01M | -150.01M | -599.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $17.63B | 33.55 | 17.85% | 0.79% | 8.01% | 2.67% | |
77 Outperform | $12.04B | 51.41 | 12.76% | ― | 12.60% | 24.02% | |
75 Outperform | $31.30B | 29.23 | 15.29% | 1.04% | -5.24% | 45.69% | |
73 Outperform | $11.28B | 33.53 | 16.49% | 1.17% | 3.19% | 69.89% | |
68 Neutral | $16.66B | 25.70 | 17.48% | 0.96% | 0.83% | -1.32% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $14.50B | 52.01 | 4.27% | 0.97% | -4.99% | 22.16% |
On February 5, 2026, Flowserve reported strong financial results for the fourth quarter and full year 2025, with Q4 bookings rising to $1.2 billion driven by 10% aftermarket growth, and full-year bookings reaching $4.7 billion, including about $400 million in nuclear awards. Reported sales grew 3.8% in 2025 to $4.73 billion, adjusted operating margin expanded to 14.8% from 11.8%, and adjusted EPS climbed 38.4% to $3.64, while cash from operations increased to $505.9 million, enabling the company to return $365 million to shareholders via dividends and repurchases. Despite a negative reported EPS in Q4 due to one-time asbestos divestiture impacts, adjusted Q4 operating margin reached 16.8% and adjusted EPS rose to $1.11, with management noting it achieved its 2027 adjusted operating margin target two years ahead of schedule. Flowserve also initiated 2026 guidance calling for 5%–7% total sales growth and adjusted EPS of $4.00–$4.20, and set 2030 targets that include mid-single-digit organic sales growth, roughly 20% adjusted operating margins and double-digit adjusted EPS growth, underscoring its confidence in healthy end markets and the momentum of its operational improvement programs. In addition, the company entered a definitive agreement on February 4, 2026, to acquire Trillium Flow Technologies’ Valves Division for $490 million in cash, a move that will expand Flowserve’s presence in nuclear, traditional power, industrial and critical infrastructure valves and actuators and is expected to be funded with a mix of cash and new debt, potentially strengthening its competitive position in mission-critical flow control applications once the deal closes, which is anticipated around mid-2026 subject to customary approvals.
The most recent analyst rating on (FLS) stock is a Buy with a $90.00 price target. To see the full list of analyst forecasts on Flowserve stock, see the FLS Stock Forecast page.
On December 29, 2025, Flowserve Corporation announced that director Kenneth I. Siegel informed the board he will not stand for re-election at the company’s 2026 annual meeting of shareholders and will continue to serve as a director until that meeting. The company said Siegel’s decision was not due to any disagreement with management or the board, and the directors expressed their appreciation for his service and contributions, signaling an orderly and non-contentious board transition for stakeholders.
The most recent analyst rating on (FLS) stock is a Hold with a $80.00 price target. To see the full list of analyst forecasts on Flowserve stock, see the FLS Stock Forecast page.
On December 11, 2025, Flowserve Corporation completed the divestiture of its legacy asbestos liabilities by selling its subsidiary BW/IP – New Mexico, Inc. to Ajax HoldCo LLC, an affiliate of Acorn Investment Partners. This transaction, which involved a total capitalization of approximately $219 million, allows Flowserve to remove these liabilities from its balance sheet and indemnifies the company from future financial exposure related to these liabilities. As a result, Flowserve expects a one-time loss of approximately $140 million in the fourth quarter of 2025, which will be excluded from adjusted earnings per share.
The most recent analyst rating on (FLS) stock is a Buy with a $85.00 price target. To see the full list of analyst forecasts on Flowserve stock, see the FLS Stock Forecast page.